4D MOLECULAR THERAPEUTICS, INC.Stock Option Agreement • November 17th, 2020 • 4D Molecular Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 17th, 2020 Company Industry JurisdictionThis Stock Option Agreement (this “Agreement”) is made and entered into as of «Date_of_Grant» by and between 4D Molecular Therapeutics, Inc., a Delaware corporation (the “Company”), and «Participant» (“Participant”). Unless otherwise defined herein, capitalized terms used herein shall have the same defined meanings as set forth in the 4D Molecular Therapeutics, Inc. 2015 Equity Incentive Plan attached hereto as Exhibit A (the “Plan”).
4D MOLECULAR THERAPEUTICS, INC.Stock Option Agreement • August 2nd, 2019 • 4D Molecular Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 2nd, 2019 Company Industry JurisdictionThis Stock Option Agreement (this “Agreement”) is made and entered into as of «Date_of_Grant» by and between 4D Molecular Therapeutics, Inc., a Delaware corporation (the “Company”), and «Participant» (“Participant”). Unless otherwise defined herein, capitalized terms used herein shall have the same defined meanings as set forth in the 4D Molecular Therapeutics, Inc. 2015 Equity Incentive Plan attached hereto as Exhibit A (the “Plan”).